Murphy Highlights Groton’s Astrocyte Pharmaceuticals As “Innovator Of The Month”

HARTFORD–U.S. Senator Chris Murphy (D-Conn.) on Monday announced that Astrocyte Pharmaceuticals, a Groton-based clinical-stage biopharmaceuticals company, was named “Innovator of the Month” for their work to advance cerebroprotective therapies for individuals suffering from stroke, traumatic brain injury (TBI), concussions and other neurodegenerative ailments. Astrocyte’s flagship program, AST-004, has been shown to significantly reduce early brain damage in a broad range of preclinical studies and is advancing to Phase 2 patient clinical trials next year. Astrocyte is breaking new ground with their innovative approach to treating strokes and TBIs — two of the most common causes of death and disability. Read more >>